FSCR-R

Due to market price fluctuations, if you need to purchase or consult the price. You can contact us or emial to us:   sales@allicdata.com

FSCR-R, which stands for Frequency Selective Cyclic Release Rate, is a technology that is used to control the release rate of pharmaceutical products. It enables the user to manipulate the release profile and rate of a medication to meet the individual needs of the patient. The technology has been around since the early 2000s, and it has been applied to a broad range of medications, including oral, topical, and injectable products.

The technology works by combining two processes, frequency and selective cyclic release. Frequency is used to control when the medication release occurs, while selective cycling is used to adjust the rate of the release. This combination of two processes enables the user to tailor a medication release profile to the specific needs of the patient. In addition, the technology provides the ability to reduce toxicity and adverse events associated with the use of medications.

The application field of FSCR-R is varied and includes pharmaceutical products used for the treatment of numerous medical conditions. It has been used to control the release of drugs like antihypertensives, lipid-lowering agents, anticonvulsants, antiplatelet agents, antidepressants, anticoagulants, anti-inflammatory drugs, antibiotics, antitussives, and antivirals. In addition, the technology has been used in the manufacture of transdermal drug patches and suppositories.

The working principle of FSCR-R is based on the separation of two different molecules, a lipid and an active pharmaceutical ingredient (API). The lipid layer acts as a carrier, while the API acts as a gatekeeper that binds specifically to the target receptors on the cell membrane. The lipid layer, when exposed to certain frequencies of energy, creates pores in the cell membrane, in which the API can pass through and reach its target receptor. This mechanism enables the API to be released over a certain period of time, thus controlling its release profile.

In conclusion, Frequency Selective Cyclic Release Rate (FSCR-R) is a technology that is used to control the release rate of pharmaceutical products. Its application field is varied and it has been used in the manufacture of transdermal patches and suppositories. The technology works by combining two processes, frequency and selective cyclic release, in order to tailor a drug release profile to meet the specific needs of the patient.

The specific data is subject to PDF, and the above content is for reference